Evidence map›Paper›PMID 36929179›Full record

ArticleAngewandte Chemie (International ed. in English)2023

Bifunctional Iminophosphorane-Catalyzed Enantioselective Nitroalkane Addition to Unactivated α,β-Unsaturated Esters.

Daniel Rozsar, Alistair J M Farley, Iain McLauchlan, Benjamin D A Shennan, Ken Yamazaki, Darren J Dixon

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel RozsarDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.ORCID http://orcid.org/0000-0002-0516-1722
Alistair J M FarleyDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.ORCID http://orcid.org/0000-0001-5578-6790
Iain McLauchlanDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.
Benjamin D A ShennanDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.ORCID http://orcid.org/0000-0003-4516-0510
Ken YamazakiDivision of Applied Chemistry, Okayama University, 700-8530, Tsushimanaka, Okayama, Japan.ORCID http://orcid.org/0000-0002-2039-4321
Darren J DixonDepartment of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK.ORCID http://orcid.org/0000-0003-2456-5236

Funding

Engineering and Physical Sciences Research Council EP/L015838/ 1
6 · The paper itself

Abstract

Herein we describe the enantioselective intermolecular conjugate addition of nitroalkanes to unactivated α,β-unsaturated esters, catalyzed by a bifunctional iminophosphorane (BIMP) superbase. The transformation provides the most direct access to pharmaceutically relevant enantioenriched γ-nitroesters, utilizing feedstock chemicals, with unprecedented selectivity. The methodology exhibits a broad substrate scope, including β-(fluoro)alkyl, aryl and heteroaryl substituted electrophiles, and was successfully applied on a gram scale with reduced catalyst loading, and, additionally, catalyst recovery was carried out. The formal synthesis of a range of drug molecules, and an enantioselective synthesis of (S)-rolipram were achieved. Additionally, computational studies revealed key reaction intermediates and transition state structures, and provided rationale for high enantioselectivities, in good agreement with experimental results.

Indexed as

Asymmetric CatalysisC−C Bond FormationConjugate AdditionEnantioselective SynthesisOrganocatalysis

Identifiers

PMID36929179
PMCPMC10946890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.